stockrow
Friday 6 November 2026
Export CELC’s income statement to Excel — free account
Celcuity, Inc.
CELC Healthcare Biotechnology
- EPS
- −38.5%
- Free cash flow
- −53.3%
- Total debt
- +658.7%
Quarter to June 2026, against a year earlier
65.85
1.81
+2.83%
Follow CELC
Alert me
Celcuity, Inc. (CELC) EBITDA
Celcuity, Inc.'s EBITDA for fiscal 2025 was −$168.9M, compared with −$111.8M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$204.0M. Over the past ten years it has ranged from −$168.9M (fiscal 2025) to −$2.2M (fiscal 2015) — the current reading is the lowest in ten years. EBITDA has fallen for 6 consecutive fiscal years. Celcuity, Inc. ranks 510th of 594 Biotechnology companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | −$168.9M | — |
| FY2024 | −$111.8M | — |
| FY2023 | −$65.8M | — |
| FY2022 | −$38.8M | — |
| FY2021 | −$27.8M | — |
| FY2020 | −$9.2M | — |
| FY2019 | −$7.5M | — |
| FY2018 | −$7.7M | — |
| FY2017 | −$5.8M | — |
| FY2016 | −$3.3M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | −$64.8M | — |
| Mar 2026 | −$49.2M | — |
| Dec 2025 | −$47.9M | — |
| Sep 2025 | −$42.0M | — |
| 36 more quarters | Free account |
Against its own ten years
Low −$168.9M
High −$2.2M
Ten-year median
−$9.2M
Current reading's percentile
9
EBITDA against peers
| Company | EBITDA |
|---|---|
| ELVN Enliven Therapeutics, Inc. compare | −$123.8M |
| CELC Celcuity, Inc. | −$204.0M |
| IDYA IDEAYA Biosciences, Inc. compare | −$463.5M |
| VRDN Viridian Therapeutics, Inc. compare | −$474.6M |
| DNLI Denali Therapeutics Inc. compare | −$524.5M |
| DYN Dyne Therapeutics, Inc. compare | −$536.1M |
| VKTX Viking Therapeutics, Inc. compare | −$652.8M |
| TARS Tarsus Pharmaceuticals, Inc. compare | −$695.5M |
| TLX Telix Pharmaceuticals Limited compare | — |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item